Do analysts rate FONR or MLSS?

Milestone Scientific has a consensus price target of $1.00, indicating a potential upside of 235.35%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than Fonar. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fonar 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Milestone Scientific (MLSS) Competitors

$0.30 -0.03 (-9.66%)

Closing price 06/23/2026 04:00 PM Eastern

Extended Trading

$0.29 -0.01 (-2.41%)

As of 05:06 AM Eastern

Compare

MLSS vs. NNOX, RCEL, MBOT, FONR, and LAKE

Should you buy Milestone Scientific stock or one of its competitors? MarketBeat compares Milestone Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Milestone Scientific include Nano-X Imaging (NNOX), Avita Medical (RCEL), Microbot Medical (MBOT), Fonar (FONR), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry.

How does Milestone Scientific compare to Nano-X Imaging?

Nano-X Imaging (NASDAQ:NNOX) and Milestone Scientific (NYSE:MLSS) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

Nano-X Imaging currently has a consensus price target of $5.00, suggesting a potential upside of 231.13%. Milestone Scientific has a consensus price target of $1.00, suggesting a potential upside of 235.35%. Given Milestone Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Milestone Scientific is more favorable than Nano-X Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Milestone Scientific has lower revenue, but higher earnings than Nano-X Imaging. Milestone Scientific is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	8.07	-$75.02M	-$1.59	N/A
Milestone Scientific	$8.90M	2.96	-$6.93M	-$0.05	N/A

In the previous week, Nano-X Imaging had 23 more articles in the media than Milestone Scientific. MarketBeat recorded 23 mentions for Nano-X Imaging and 0 mentions for Milestone Scientific. Nano-X Imaging's average media sentiment score of 0.08 beat Milestone Scientific's score of 0.00 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company	Overall Sentiment
Nano-X Imaging	Neutral
Milestone Scientific	Neutral

Nano-X Imaging has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market.

Milestone Scientific has a net margin of -52.01% compared to Nano-X Imaging's net margin of -790.87%. Milestone Scientific's return on equity of -60.26% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-790.87%	-64.65%	-57.27%
Milestone Scientific	-52.01%	-60.26%	-40.23%

21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 12.5% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Nano-X Imaging and Milestone Scientific tied by winning 8 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to Avita Medical?

Milestone Scientific (NYSE:MLSS) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Milestone Scientific has higher earnings, but lower revenue than Avita Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	2.96	-$6.93M	-$0.05	N/A
Avita Medical	$71.61M	1.68	-$48.59M	-$1.57	N/A

Milestone Scientific has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market.

Milestone Scientific currently has a consensus target price of $1.00, indicating a potential upside of 235.35%. Avita Medical has a consensus target price of $7.25, indicating a potential upside of 84.95%. Given Milestone Scientific's stronger consensus rating and higher probable upside, equities analysts plainly believe Milestone Scientific is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Avita Medical had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 1 mentions for Avita Medical and 0 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.00 equaled Avita Medical'saverage media sentiment score.

Company	Overall Sentiment
Milestone Scientific	Neutral
Avita Medical	Neutral

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 12.5% of Milestone Scientific shares are owned by company insiders. Comparatively, 2.8% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Milestone Scientific has a net margin of -52.01% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Avita Medical	-62.67%	N/A	-78.92%

Summary

Milestone Scientific beats Avita Medical on 8 of the 15 factors compared between the two stocks.

How does Milestone Scientific compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by insiders. Comparatively, 12.5% of Milestone Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Microbot Medical has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market.

In the previous week, Microbot Medical had 2 more articles in the media than Milestone Scientific. MarketBeat recorded 2 mentions for Microbot Medical and 0 mentions for Milestone Scientific. Microbot Medical's average media sentiment score of 0.67 beat Milestone Scientific's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Microbot Medical	Positive
Milestone Scientific	Neutral

Microbot Medical presently has a consensus target price of $6.63, indicating a potential upside of 264.01%. Milestone Scientific has a consensus target price of $1.00, indicating a potential upside of 235.35%. Given Microbot Medical's higher possible upside, analysts clearly believe Microbot Medical is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Milestone Scientific has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
Milestone Scientific	$8.90M	2.96	-$6.93M	-$0.05	N/A

Microbot Medical has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Microbot Medical's return on equity of -21.84% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
Milestone Scientific	-52.01%	-60.26%	-40.23%

Summary

Microbot Medical beats Milestone Scientific on 9 of the 15 factors compared between the two stocks.

How does Milestone Scientific compare to Fonar?

Fonar (NASDAQ:FONR) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Milestone Scientific has a consensus price target of $1.00, indicating a potential upside of 235.35%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than Fonar.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fonar	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Fonar has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market.

Fonar has higher revenue and earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fonar	$105.34M	1.12	$8.33M	$1.00	19.09
Milestone Scientific	$8.90M	2.96	-$6.93M	-$0.05	N/A

Fonar has a net margin of 6.35% compared to Milestone Scientific's net margin of -52.01%. Fonar's return on equity of 4.12% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fonar	6.35%	4.12%	3.07%
Milestone Scientific	-52.01%	-60.26%	-40.23%

50.6% of Fonar shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 7.9% of Fonar shares are owned by company insiders. Comparatively, 12.5% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Fonar had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 1 mentions for Fonar and 0 mentions for Milestone Scientific. Fonar's average media sentiment score of 0.00 equaled Milestone Scientific'saverage media sentiment score.

Company	Overall Sentiment
Fonar	Neutral
Milestone Scientific	Neutral

Summary

Fonar beats Milestone Scientific on 9 of the 15 factors compared between the two stocks.

How does Milestone Scientific compare to Lakeland Industries?

Milestone Scientific (NYSE:MLSS) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment.

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are owned by institutional investors. 12.5% of Milestone Scientific shares are owned by insiders. Comparatively, 3.4% of Lakeland Industries shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Milestone Scientific presently has a consensus target price of $1.00, indicating a potential upside of 235.35%. Lakeland Industries has a consensus target price of $16.00, indicating a potential upside of 53.55%. Given Milestone Scientific's stronger consensus rating and higher possible upside, equities research analysts plainly believe Milestone Scientific is more favorable than Lakeland Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Lakeland Industries	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Lakeland Industries has a net margin of -10.87% compared to Milestone Scientific's net margin of -52.01%. Lakeland Industries' return on equity of -6.64% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Lakeland Industries	-10.87%	-6.64%	-4.13%

Milestone Scientific has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market. Comparatively, Lakeland Industries has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market.

In the previous week, Lakeland Industries had 2 more articles in the media than Milestone Scientific. MarketBeat recorded 2 mentions for Lakeland Industries and 0 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.00 equaled Lakeland Industries'average media sentiment score.

Company	Overall Sentiment
Milestone Scientific	Neutral
Lakeland Industries	Neutral

Milestone Scientific has higher earnings, but lower revenue than Lakeland Industries. Milestone Scientific is trading at a lower price-to-earnings ratio than Lakeland Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	2.96	-$6.93M	-$0.05	N/A
Lakeland Industries	$192.65M	0.53	-$25.31M	-$2.13	N/A

Summary

Lakeland Industries beats Milestone Scientific on 8 of the 15 factors compared between the two stocks.

Get Milestone Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MLSS vs. The Competition

Export

Metric	Milestone Scientific	Surgical appliances & supplies Industry	Medical Sector	NYSE Exchange
Market Cap	$26.38M	$22.05M	$6.44B	$23.25B
Dividend Yield	N/A	N/A	2.69%	4.07%
P/E Ratio	-4.26	13.97	24.66	31.08
Price / Sales	2.96	1.31	527.00	105.78
Price / Cash	N/A	12.80	44.82	24.45
Price / Book	2.71	1.24	10.75	4.64
Net Income	-$6.93M	-$3.92M	$3.56B	$1.07B
7 Day Performance	-12.27%	-1.19%	1.00%	0.15%
1 Month Performance	-22.14%	2.98%	0.43%	0.18%
1 Year Performance	-62.26%	-31.70%	29.69%	23.21%

Milestone Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLSS Milestone Scientific	N/A	$0.30 -9.7%	$1.00 +235.3%	-62.7%	$26.38M	$8.90M	N/A	30	Gap Down
NNOX Nano-X Imaging	3.462 of 5 stars	$1.76 +2.9%	$5.00 +184.1%	-69.5%	$122.48M	$13.02M	N/A	190	Trending News
RCEL Avita Medical	3.1091 of 5 stars	$3.91 -1.5%	$7.25 +85.4%	-23.7%	$120.34M	$72.35M	N/A	130	Positive News
MBOT Microbot Medical	2.7535 of 5 stars	$1.78 -2.2%	$6.63 +272.2%	-22.9%	$119.55M	N/A	N/A	20	Gap Up
FONR Fonar	2.1674 of 5 stars	$19.09 flat	N/A	N/A	$117.84M	$105.34M	19.09	480	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MLSS) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Milestone Scientific (MLSS) Competitors

MLSS vs. NNOX, RCEL, MBOT, FONR, and LAKE

How does Milestone Scientific compare to Nano-X Imaging?

Summary

How does Milestone Scientific compare to Avita Medical?

Summary

How does Milestone Scientific compare to Microbot Medical?

Summary

How does Milestone Scientific compare to Fonar?

Summary

How does Milestone Scientific compare to Lakeland Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Milestone Scientific (MLSS) Competitors

MLSS vs. NNOX, RCEL, MBOT, FONR, and LAKE

How does Milestone Scientific compare to Nano-X Imaging?

Do analysts prefer NNOX or MLSS?

Which has higher earnings & valuation, NNOX or MLSS?

Does the media prefer NNOX or MLSS?

Which has more risk and volatility, NNOX or MLSS?

Is NNOX or MLSS more profitable?

Do institutionals & insiders have more ownership in NNOX or MLSS?

Summary

How does Milestone Scientific compare to Avita Medical?

Which has better valuation & earnings, MLSS or RCEL?

Which has more risk and volatility, MLSS or RCEL?

Do analysts rate MLSS or RCEL?

Does the media favor MLSS or RCEL?

Do institutionals & insiders hold more shares of MLSS or RCEL?

Is MLSS or RCEL more profitable?

Summary

How does Milestone Scientific compare to Microbot Medical?

Do insiders and institutionals believe in MBOT or MLSS?

Which has more risk & volatility, MBOT or MLSS?

Does the media prefer MBOT or MLSS?

Do analysts rate MBOT or MLSS?

Which has better earnings & valuation, MBOT or MLSS?

Is MBOT or MLSS more profitable?

Summary

How does Milestone Scientific compare to Fonar?

Do analysts rate FONR or MLSS?

Which has more volatility & risk, FONR or MLSS?

Which has higher valuation & earnings, FONR or MLSS?

Is FONR or MLSS more profitable?

Do insiders & institutionals believe in FONR or MLSS?

Does the media prefer FONR or MLSS?

Summary

How does Milestone Scientific compare to Lakeland Industries?

Do institutionals and insiders believe in MLSS or LAKE?

Do analysts rate MLSS or LAKE?

Is MLSS or LAKE more profitable?

Which has more volatility and risk, MLSS or LAKE?

Does the media prefer MLSS or LAKE?

Which has preferable earnings and valuation, MLSS or LAKE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools